APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aminoglycosides Antibiotics

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

Selected research

Market Structure

Global Aminoglycosides Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchAminoglycosides Antibiotics Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Aminoglycosides Antibiotics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Aminoglycosides Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aminoglycosides Antibiotics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Aminoglycosides Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.

The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.

Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

Read the full market overview

Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.

Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

This report provides an overview of the global Aminoglycosides Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aminoglycosides Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aminoglycosides Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aminoglycosides Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Aminoglycosides Antibiotics Segment by Company

Jemicare

Teva

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla

Pfizer

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

Aminoglycosides Antibiotics Segment by Type

Neomycin

Tobramycin

Gentamicin

Amikacin

Etimicin

Others

Aminoglycosides Antibiotics Segment by Application

Hospital

Clinic

Post Care Facility

Government & Military

Others

Aminoglycosides Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aminoglycosides Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aminoglycosides Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aminoglycosides Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aminoglycosides Antibiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aminoglycosides Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Aminoglycosides Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Aminoglycosides Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Aminoglycosides Antibiotics Industry Trends Table 2. Aminoglycosides Antibiotics Industry Drivers Table 3. Aminoglycosides Antibiotics Industry Opportunities and Challenges Table 4. Aminoglycosides Antibiotics Industry Restraints Table 5. Global Aminoglycosides Antibiotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Aminoglycosides Antibiotics Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers Table 9. Global Aminoglycosides Antibiotics Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Aminoglycosides Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Aminoglycosides Antibiotics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Aminoglycosides Antibiotics Manufacturers, Product Type & Application Table 13. Global Aminoglycosides Antibiotics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Aminoglycosides Antibiotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Neomycin Table 17. Major Manufacturers of Tobramycin Table 18. Major Manufacturers of Gentamicin Table 19. Major Manufacturers of Amikacin Table 20. Major Manufacturers of Etimicin Table 21. Major Manufacturers of Others Table 22. Global Aminoglycosides Antibiotics Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 23. Global Aminoglycosides Antibiotics Sales by Type (2021-2026) & (M Units) Table 24. Global Aminoglycosides Antibiotics Sales by Type (2027-2032) & (M Units) Table 25. Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2026) Table 26. Global Aminoglycosides Antibiotics Sales Market Share by Type (2027-2032) Table 27. Global Aminoglycosides Antibiotics Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 28. Global Aminoglycosides Antibiotics Revenue by Type (2021-2026) & (M Units) Table 29. Global Aminoglycosides Antibiotics Revenue by Type (2027-2032) & (M Units) Table 30. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2026) Table 31. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Clinic Table 34. Major Manufacturers of Post Care Facility Table 35. Major Manufacturers of Government & Military Table 36. Major Manufacturers of Others Table 37. Global Aminoglycosides Antibiotics Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Aminoglycosides Antibiotics Sales by Application (2021-2026) & (M Units) Table 39. Global Aminoglycosides Antibiotics Sales by Application (2027-2032) & (M Units) Table 40. Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2026) Table 41. Global Aminoglycosides Antibiotics Sales Market Share by Application (2027-2032) Table 42. Global Aminoglycosides Antibiotics Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 43. Global Aminoglycosides Antibiotics Revenue by Application (2021-2026) & (M Units) Table 44. Global Aminoglycosides Antibiotics Revenue by Application (2027-2032) & (M Units) Table 45. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2026) Table 46. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2027-2032) Table 47. Global Aminoglycosides Antibiotics Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 48. Global Aminoglycosides Antibiotics Sales by Region (2021-2026) & (M Units) Table 49. Global Aminoglycosides Antibiotics Sales Market Share by Region (2021-2026) Table 50. Global Aminoglycosides Antibiotics Sales Forecasted by Region (2027-2032) & (M Units) Table 51. Global Aminoglycosides Antibiotics Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. North America Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 54. North America Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 55. Europe Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Europe Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 57. Europe Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 58. Asia Pacific Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. Asia Pacific Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 60. Asia Pacific Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 61. South America, Middle East and Africa Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 62. South America, Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2021-2026) & (M Units) Table 63. South America, Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2027-2032) & (M Units) Table 64. Global Aminoglycosides Antibiotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Aminoglycosides Antibiotics Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Aminoglycosides Antibiotics Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2021-2026) Table 68. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2027-2032) Table 69. Jemicare Company Information Table 70. Jemicare Business Overview Table 71. Jemicare Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Jemicare Aminoglycosides Antibiotics Product Portfolio Table 73. Jemicare Recent Development Table 74. Teva Company Information Table 75. Teva Business Overview Table 76. Teva Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Teva Aminoglycosides Antibiotics Product Portfolio Table 78. Teva Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis Aminoglycosides Antibiotics Product Portfolio Table 83. Novartis Recent Development Table 84. Fangyuan-pharma Company Information Table 85. Fangyuan-pharma Business Overview Table 86. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio Table 88. Fangyuan-pharma Recent Development Table 89. Aike Pharmaceutical Company Information Table 90. Aike Pharmaceutical Business Overview Table 91. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio Table 93. Aike Pharmaceutical Recent Development Table 94. Cipla Company Information Table 95. Cipla Business Overview Table 96. Cipla Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Cipla Aminoglycosides Antibiotics Product Portfolio Table 98. Cipla Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Aminoglycosides Antibiotics Product Portfolio Table 103. Pfizer Recent Development Table 104. Fresenius Kabi Company Information Table 105. Fresenius Kabi Business Overview Table 106. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio Table 108. Fresenius Kabi Recent Development Table 109. Sun Pharma Company Information Table 110. Sun Pharma Business Overview Table 111. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Sun Pharma Aminoglycosides Antibiotics Product Portfolio Table 113. Sun Pharma Recent Development Table 114. Hikma Company Information Table 115. Hikma Business Overview Table 116. Hikma Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hikma Aminoglycosides Antibiotics Product Portfolio Table 118. Hikma Recent Development Table 119. Lannett Company Company Information Table 120. Lannett Company Business Overview Table 121. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Lannett Company Aminoglycosides Antibiotics Product Portfolio Table 123. Lannett Company Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Aminoglycosides Antibiotics Distributors List Table 127. Aminoglycosides Antibiotics Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Aminoglycosides Antibiotics Product Image Figure 2. Global Aminoglycosides Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aminoglycosides Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Aminoglycosides Antibiotics Sales (2021-2032) & (M Units) Figure 5. Global Aminoglycosides Antibiotics Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Aminoglycosides Antibiotics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Neomycin Image Figure 9. Tobramycin Image Figure 10. Gentamicin Image Figure 11. Amikacin Image Figure 12. Etimicin Image Figure 13. Others Image Figure 14. Global Aminoglycosides Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Aminoglycosides Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2032) Figure 17. Global Aminoglycosides Antibiotics Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 18. Global Aminoglycosides Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Post Care Facility Image Figure 23. Government & Military Image Figure 24. Others Image Figure 25. Global Aminoglycosides Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Aminoglycosides Antibiotics Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2032) Figure 28. Global Aminoglycosides Antibiotics Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 29. Global Aminoglycosides Antibiotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2032) Figure 31. North America Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 32. North America Aminoglycosides Antibiotics Sales Market Share by Country (2021-2032) Figure 33. U.S. Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Canada Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Mexico Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Europe Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Europe Aminoglycosides Antibiotics Sales Market Share by Country (2021-2032) Figure 38. Germany Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 39. France Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 40. U.K. Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Italy Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Netherlands Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Asia Pacific Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Asia Pacific Aminoglycosides Antibiotics Sales Market Share by Country (2021-2032) Figure 45. China Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Japan Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Korea Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Southeast Asia Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 49. India Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Australia Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South America, Middle East and Africa Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 52. South America, Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Country (2021-2032) Figure 53. Brazil Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 54. South Africa Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Saudi Arabia Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Turkey Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Argentina Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 58. UAE Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 59. Egypt Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 60. Chile Aminoglycosides Antibiotics Sales and Growth Rate (2021-2032) & (M Units) Figure 61. Global Aminoglycosides Antibiotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Aminoglycosides Antibiotics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Figure 64. North America Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Figure 66. Europe Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Aminoglycosides Antibiotics Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Aminoglycosides Antibiotics Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Aminoglycosides Antibiotics Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Etimicin
  • Others
Applications
  • Hospital
  • Clinic
  • Post Care Facility
  • Government & Military
  • Others
Companies covered
  • Jemicare
  • Teva
  • Novartis
  • Fangyuan-pharma
  • Aike Pharmaceutical
  • Cipla
  • Pfizer
  • Fresenius Kabi
  • Sun Pharma
  • Hikma
  • Lannett Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aminoglycosides Antibiotics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aminoglycosides Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Aminoglycosides Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Aminoglycosides Antibiotics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Aminoglycosides Antibiotics Market Dynamics
  1. 2.1 Aminoglycosides Antibiotics Industry Trends
  2. 2.2 Aminoglycosides Antibiotics Industry Drivers
  3. 2.3 Aminoglycosides Antibiotics Industry Opportunities and Challenges
  4. 2.4 Aminoglycosides Antibiotics Industry Restraints
3 Aminoglycosides Antibiotics Market by Manufacturers
  1. 3.1 Global Aminoglycosides Antibiotics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Aminoglycosides Antibiotics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Aminoglycosides Antibiotics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Aminoglycosides Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aminoglycosides Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Aminoglycosides Antibiotics Manufacturers, Product Type & Application
  7. 3.7 Global Aminoglycosides Antibiotics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aminoglycosides Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aminoglycosides Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aminoglycosides Antibiotics Tier 1, Tier 2, and Tier 3
4 Aminoglycosides Antibiotics Market by Type
  1. 4.1 Aminoglycosides Antibiotics Type Introduction
  2. 4.1.1 Neomycin
  3. 4.1.2 Tobramycin
  4. 4.1.3 Gentamicin
  5. 4.1.4 Amikacin
  6. 4.1.5 Etimicin
  7. 4.1.6 Others
  8. 4.2 Global Aminoglycosides Antibiotics Sales by Type
  9. 4.2.1 Global Aminoglycosides Antibiotics Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Aminoglycosides Antibiotics Sales by Type (2021-2032)
  11. 4.2.3 Global Aminoglycosides Antibiotics Sales Market Share by Type (2021-2032)
  12. 4.3 Global Aminoglycosides Antibiotics Revenue by Type
  13. 4.3.1 Global Aminoglycosides Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Aminoglycosides Antibiotics Revenue by Type (2021-2032)
  15. 4.3.3 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2021-2032)
5 Aminoglycosides Antibiotics Market by Application
  1. 5.1 Aminoglycosides Antibiotics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Post Care Facility
  5. 5.1.4 Government & Military
  6. 5.1.5 Others
  7. 5.2 Global Aminoglycosides Antibiotics Sales by Application
  8. 5.2.1 Global Aminoglycosides Antibiotics Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Aminoglycosides Antibiotics Sales by Application (2021-2032)
  10. 5.2.3 Global Aminoglycosides Antibiotics Sales Market Share by Application (2021-2032)
  11. 5.3 Global Aminoglycosides Antibiotics Revenue by Application
  12. 5.3.1 Global Aminoglycosides Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Aminoglycosides Antibiotics Revenue by Application (2021-2032)
  14. 5.3.3 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2021-2032)
6 Global Aminoglycosides Antibiotics Sales by Region
  1. 6.1 Global Aminoglycosides Antibiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aminoglycosides Antibiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Aminoglycosides Antibiotics Sales by Region (2021-2026)
  4. 6.2.2 Global Aminoglycosides Antibiotics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Aminoglycosides Antibiotics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Aminoglycosides Antibiotics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Aminoglycosides Antibiotics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Aminoglycosides Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Aminoglycosides Antibiotics Revenue by Region
  1. 7.1 Global Aminoglycosides Antibiotics Revenue by Region
  2. 7.1.1 Global Aminoglycosides Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Aminoglycosides Antibiotics Revenue by Region (2021-2026)
  4. 7.1.3 Global Aminoglycosides Antibiotics Revenue by Region (2027-2032)
  5. 7.1.4 Global Aminoglycosides Antibiotics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Aminoglycosides Antibiotics Revenue (2021-2032)
  8. 7.2.2 North America Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Aminoglycosides Antibiotics Revenue (2021-2032)
  11. 7.3.2 Europe Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Aminoglycosides Antibiotics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Aminoglycosides Antibiotics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Aminoglycosides Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jemicare
  2. 8.1.1 Jemicare Company Information
  3. 8.1.2 Jemicare Business Overview
  4. 8.1.3 Jemicare Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jemicare Aminoglycosides Antibiotics Product Portfolio
  6. 8.1.5 Jemicare Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Aminoglycosides Antibiotics Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Aminoglycosides Antibiotics Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Fangyuan-pharma
  20. 8.4.1 Fangyuan-pharma Company Information
  21. 8.4.2 Fangyuan-pharma Business Overview
  22. 8.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio
  24. 8.4.5 Fangyuan-pharma Recent Developments
  25. 8.5 Aike Pharmaceutical
  26. 8.5.1 Aike Pharmaceutical Company Information
  27. 8.5.2 Aike Pharmaceutical Business Overview
  28. 8.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio
  30. 8.5.5 Aike Pharmaceutical Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Aminoglycosides Antibiotics Product Portfolio
  36. 8.6.5 Cipla Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Aminoglycosides Antibiotics Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Aminoglycosides Antibiotics Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Hikma
  56. 8.10.1 Hikma Company Information
  57. 8.10.2 Hikma Business Overview
  58. 8.10.3 Hikma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Aminoglycosides Antibiotics Product Portfolio
  60. 8.10.5 Hikma Recent Developments
  61. 8.11 Lannett Company
  62. 8.11.1 Lannett Company Company Information
  63. 8.11.2 Lannett Company Business Overview
  64. 8.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lannett Company Aminoglycosides Antibiotics Product Portfolio
  66. 8.11.5 Lannett Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aminoglycosides Antibiotics Value Chain Analysis
  2. 9.1.1 Aminoglycosides Antibiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aminoglycosides Antibiotics Production Mode & Process
  6. 9.2 Aminoglycosides Antibiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aminoglycosides Antibiotics Distributors
  9. 9.2.3 Aminoglycosides Antibiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst